Description of patients and genotyping characteristics
| Patient ID | Diagnosis | Molecular finding | Gender | BRLMM (%)* | Average heterozygosity (%) |
| SRS-hypo-1 | SRS | H19 hypomethylation | Male | 99.33 | 26.54 |
| SRS-hypo-2 | SRS | H19 hypomethylation | Male | 99.12 | 26.88 |
| SRS-hypo-3 | SRS | H19 hypomethylation | Female | 99.47 | 27.00 |
| SRS-hypo-4 | SRS | H19 hypomethylation | Female | 99.37 | 27.26 |
| SRS-hypo-5 | SRS | H19 hypomethylation | Female | 99.19 | 27.24 |
| SRS-hypo-6 | SRS | H19 hypomethylation | Male | 99.17 | 26.20 |
| SRS-hypo-7 | SRS | H19 hypomethylation | Female | 99.28 | 26.99 |
| SRS-hypo-8 | SRS | H19 hypomethylation | Female | 88.05 | 35.24 |
| SRS-hypo-9 | SRS | H19 hypomethylation | Male | 98.63 | 27.22 |
| SRS-hypo-10 | SRS | H19 hypomethylation | Male | 98.95 | 26.36 |
| SRS-ue-1 | SRS | None, idiopathic | Female | 99.48 | 26.60 |
| SRS-ue-2 | SRS | None, idiopathic | Female | 99.60 | 26.94 |
| SRS-ue-3 | SRS-like | None, idiopathic | Female | 99.53 | 27.00 |
| SRS-ue-4 | SRS-like | None, idiopathic | Female | 99.46 | 27.18 |
| SRS-ue-5 | SRS-like | None, idiopathic | Male | 99.27 | 26.66 |
| SRS-ue-6 | SRS | None, idiopathic | Female | 97.88 | 27.04 |
| SRS-ue-7 | SRS | None, idiopathic | Female | 99.26 | 27.13 |
| SRS-ue-8 | SRS | None, idiopathic | Female | 99.24 | 27.46 |
| SRS-ue-9 | SRS | None, idiopathic | Female | 99.26 | 26.98 |
| SRS-ue-10 | SRS | None, idiopathic | Female | 99.29 | 27.23 |
| SRS-ue-11 | SRS-like | None, idiopathic | Male | 99.66 | 26.44 |
| SRS-ue-12 | SRS | None, idiopathic | Male | 98.78 | 26.74 |
↵* BRLMM refers to the call rate with the Affymetrix BRLMM genotyping algorithm.
SRS, Silver–Russell syndrome.